A Qualitative Study of Cytomegalovirus Awareness and Experience in Kidney Transplant Recipients
Journal of Transplantation · 2026-01 · 2026 (1)
DOI: 10.1155/joot/1290788 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Journal of Transplantation, online erschienen am 26.05.2026. Verfasst von Afolarin A Otunla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Department of Surgical Biotechnology, University College London, London, NW3 2PP, UK, ucl.ac.uk. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kidney Research UK.
Abstract (Originalsprache)
Objectives
To assess the experiences of CMV among kidney transplant recipients in a single transplant centre, focusing on their awareness of CMV, the impact of the disease on their quality of life, and their perceived effectiveness of anti‐CMV therapy. Subjects/Patients (or Materials) and Methods We carried out semistructured interviews with 50 adult recipients who had undergone kidney transplantation within the last two years in our centre. Participants were divided into those who had experienced CMV (CMV group, n = 25) and those who had not (non‐CMV group, n = 25). Data were collected and analysed using inductive qualitative methods, with embedded quantitative descriptive analysis.
Results
Awareness of CMV was low, particularly among those who had not experienced the virus. 32% ( n = 8) of the non‐CMV group were aware of CMV, compared to 88% ( n = 22) in the CMV group ( p < 0.001). Most CMV‐affected participants (78%) reported no symptoms, and the impact on mood and social life was minimal. CMV treatments were rated highly effective, with a preference for pre‐emptive management. There was a strong consensus on the need for better patient education about CMV, with suggestions for more direct communication through healthcare professionals.
Conclusion
This study is the first to provide a comprehensive evaluation of CMV awareness and management from the perspective of kidney transplant recipients in the UK. We highlight a significant gap in CMV awareness among kidney transplant recipients, emphasizing the need for improved educational efforts. Enhanced patient education, particularly through multimedia patient educational tools, could bridge the knowledge gap and ensure better management of CMV in this population. These insights are vital for shaping future patient care strategies and could significantly impact clinical practice, particularly in post‐transplant care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Department of Surgical Biotechnology, University College London, London, NW3 2PP, UK, ucl.ac.uk.
- Department of Targeted Intervention, University College London, London, W1W 7TY, UK, ucl.ac.uk.
- Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK, ucl.ac.uk.
- Department of Nephrology and Transplantation, Royal Free Hospital, London, NW3 2QG, UK, nhs.uk.
ORCID-Profile: Afolarin A Otunla, Katie Gilchrist, Reza Motallebzadeh
Förderung
- Kidney Research UK
Zitieren
APA
Otunla, A. A., McLeod, A., Gilchrist, K., Vindrola-Padros, C., & Motallebzadeh, R. (2026). A Qualitative Study of Cytomegalovirus Awareness and Experience in Kidney Transplant Recipients. Journal of Transplantation, 2026(1). https://doi.org/10.1155/joot/1290788
Vancouver
Otunla AA, McLeod A, Gilchrist K, Vindrola-Padros C, Motallebzadeh R. A Qualitative Study of Cytomegalovirus Awareness and Experience in Kidney Transplant Recipients. Journal of Transplantation. 2026;2026(1). doi:10.1155/joot/1290788
BibTeX
@article{Otunla2026,
author = {Otunla, Afolarin A and McLeod, Ailey and Gilchrist, Katie and Vindrola-Padros, Cecilia and Motallebzadeh, Reza},
title = {A Qualitative Study of Cytomegalovirus Awareness and Experience in Kidney Transplant Recipients},
journal = {Journal of Transplantation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/joot/1290788}
}
EUVIMED